|
Market Closed -
NYSE
16:00:00 2026-10-16 EDT
|
5-day change | 1st Jan Change | ||
| 0.9783 USD | -1.21% |
|
-1.58% | -41.42% |
| 09-30 | EARNINGS: Generation Essentials interim profit jumps to USD28 million | AN |
| 08-07 | Lineage Cell Therapeutics, Inc., Q2 2026 Earnings Call, Aug 06, 2026 |
Stock exchange
NYSE
LCTX 0.9783 $
-1.21%
1.28M
$
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
| LCTX | 0.9783USD | -1.21% | 1.28M $ | ||
CBOE
| LCTX | 0.9886USD | +0.25% | 32.37K $ | |
|
TEL AVIV STOCK EXCHANGE
| LCTX | 293.20ILa | +1.07% | 646K ILa | |
|
Tradegate
| BT3 | 0.8800EUR | -0.11% | 0.88 € | |
|
Deutsche Boerse AG
| BT3 | 0.8380EUR | -2.22% | 0 € | |
|
Börse Stuttgart
| BT3 | 0.8600EUR | -0.46% | 0 € | |
|
Boerse Muenchen
| BT3 | 0.8740EUR | -1.13% | 0 € |
Quotes 5-day view: Lineage Cell Therapeutics, Inc.
Delayed Quote NYSE
| 2026-10-12 | 2026-10-13 | 2026-10-14 | 2026-10-15 | 2026-10-16 | |
|---|---|---|---|---|---|
| Last | US$0.9541 | US$0.9083 | US$0.9175 | US$0.9903 | US$0.9783 |
| Volume | 1,686,970 | 1,784,674 | 2,201,249 | 1,424,713 | 1,308,653 |
| Change | -4.01% | -4.80% | +1.01% | +7.93% | -1.21% |
| Opening | US$0.9979 | US$0.9500 | US$0.9142 | US$0.9212 | US$0.9800 |
| High | US$0.9979 | US$0.9700 | US$0.9400 | US$0.9994 | US$1.000 |
| Low | US$0.9383 | US$0.8950 | US$0.8902 | US$0.9180 | US$0.9600 |
Performance
| 1 day | -1.21% | ||
| 1 week | -1.58% | ||
| Current month | +2.36% | ||
| 1 month | -5.02% | ||
| 3 months | -15.66% | ||
| 6 months | -42.79% | ||
| Current year | -41.42% | ||
| 1 year | -40.71% | ||
| 3 years | -19.15% | ||
| 5 years | -57.09% | ||
| 10 years | -72.36% |
Volumes
marketsDaily volume
1,308,653
Estimated daily volume
1,308,653
Avg. Volume 20 sessions
1,582,803
Daily volume ratio
0.83
Avg. Volume 20 sessions USD
1,548,456.17
Record volume 1
23,661,485
Record volume 2
22,539,712
Record volume 3
17,430,494
Capital turnover ratio
0.01
Float rotation
0.01
Basic data
Market Cap (USD)
247,419,372
Net sales (USD)
14,556,000
Number of employees
75
Sales / Employee (USD)
194,080
Free-Float
95.14%
Free-Float capitalization (USD)
235,394,751
Average Daily Capital Traded
0.63%
Indicators
Moving average 5 days
0.9497
Moving average 20 days
0.9665
Moving average 50 days
1.038
Moving average 100 days
1.123
Price spread / (MMA5)
-2.92%
Price spread / (MMA20)
-1.21%
Price spread / (MMA50)
+6.06%
Price spread / (MMA100)
+14.77%
STIM
RSI 9 days
53.73
RSI 14 days
50.25
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.21% | -1.58% | -40.71% | -19.15% | 247M | |
| +1.52% | -7.16% | +51.66% | +67.41% | 65B | |
| +1.01% | +5.99% | +10.02% | +77.89% | 51.2B | |
| -0.41% | -1.17% | -0.74% | +60.74% | 51.19B | |
| -1.53% | +2.70% | +30.48% | +41.25% | 43.93B | |
| -1.34% | +4.12% | +16.64% | +120.28% | 41.96B | |
| -5.97% | -6.22% | +228.95% | +483.48% | 38.14B | |
| +2.16% | +10.36% | +18.92% | +59.70% | 33.24B | |
| -0.90% | -10.49% | +37.09% | +1.80% | 25.2B | |
| +0.08% | +0.68% | +26.05% | +26.08% | 22.5B | |
| Average | -0.66% | -0.03% | +37.83% | +91.95% | 37.26B | |
| Weighted average by Cap. | -0.46% | +0.04% | +44.93% | +105.72% |
Historical Quotes: Lineage Cell Therapeutics, Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Latest transactions
6390.Q-zEhGmkQLw7y_31kcof7-GP3XYWQhHXPD13mKcgk2s.FISHvSLWLupWurDB1qUuqbC2lyF_L0ulWVoAydFS1SNxroK1WPZz6UvyxQ
| Date | Price | Volume | Total |
|---|---|---|---|
| 16:00:00 | 0.9783 | 87,591 | 1,226,669 |
| 15:59:59 | 0.9890 | 136 | 1,139,078 |
| 15:59:58 | 0.9890 | 100 | 1,138,942 |
| 15:59:57 | 0.9890 | 100 | 1,138,842 |
| 15:59:56 | 0.9890 | 100 | 1,138,742 |
| 15:59:56 | 0.9890 | 500 | 1,138,642 |
| 15:59:56 | 0.9890 | 200 | 1,138,142 |
| 15:59:56 | 0.9890 | 200 | 1,137,942 |
| 15:59:56 | 0.9890 | 600 | 1,137,742 |
| 15:59:55 | 0.9890 | 100 | 1,137,142 |
Price Extremes
| 1 week | 0.89 |  | 1 |
| 1 month | 0.88 | | 1.05 |
| Current year | 0.88 | | 1.98 |
| 1 year | 0.88 | | 2.09 |
| 3 years | 0.37 | | 2.09 |
| 5 years | 0.37 | | 2.71 |
| 10 years | 0.37 | | 3.96 |
Monthly variations
Annual variations
| 2026 | -41.42% | ||
| 2025 | +232.34% | ||
| 2024 | -53.90% | ||
| 2023 | -6.84% | ||
| 2022 | -52.24% | ||
| 2021 | +39.20% | ||
| 2020 | +97.75% | ||
| 2019 | -2.52% | ||
| 2018 | -57.53% | ||
| 2017 | -40.44% | ||
| 2016 | -11.95% | ||
| 2015 | +9.92% | ||
| 2014 | +3.61% | ||
| 2013 | +14.65% | ||
| 2012 | -45.96% | ||
| 2011 | -30.25% | ||
| 2010 | +96.93% | ||
| 2009 | +138.98% | ||
| 2008 | +331.71% | ||
| 2007 | +54.72% | ||
| 2006 | -14.52% | ||
| 2005 | -79.47% | ||
| 2004 | +9.42% | ||
| 2003 | -10.97% | ||
| 2002 | -66.30% | ||
| 2001 | -38.67% | ||
| 2000 | -15.49% | ||
| 1999 | -48.92% | ||
| 1998 | -8.55% | ||
| 1997 | +103.57% | ||
| 1996 | +796.00% | ||
| 1995 | +56.25% | ||
| 1994 | -74.60% | ||
| 1993 | -19.23% | ||
| 1992 | -4.88% |
- Stock Market
- Stocks
- LCTX Stock
- Quotes Lineage Cell Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
